🫀 Heart failure contributes to ~1 in 7 US deaths (457K/year)
💵 NIH $ per death:
🧬 HIV ~$717K 🧠 Alzheimer's ~$31K 🎗️ Cancer ~$13K 🫁 COPD ~$824 ❤️🩹 HF ~$440 (est.)
HF gets ~1,600× less than HIV per death
Fund HF research!!!📢
@HFSA@ACCinTouch@American_Heart
What an incredible and moving story shared today by @LGlaucomflecken at #HFSA2026. Her powerful account of her husband’s sudden cardiac arrest is a reminder of the human side of heart failure and the profound impact on patients and their families. @DGlaucomflecken
Congratulations to the 2026 HFSA Award recipients! 🏆
We're proud to recognize the individuals and teams whose leadership, innovation, research, mentorship & service are advancing heart failure care.
Meet the honorees being recognized at #HFSA2026: https://t.co/YZwqyDwuau
The DCRI and @CVCTForum have launched "Pathway to Prevention," an initiative to build regulatory and clinical pathways for cardiovascular prevention therapies. Three programs + multiple stakeholders = closing the gap between science and policy. https://t.co/A31yAubxeF
#Prevention
📺 Now available on ESC TV: a special edition of the #HFA_ESC JournalClub, recorded live from #HeartFailure26
The discussion explores the SUBCUT HF II trial, role of subcutaneous furosemide in heart failure management.
🎙️ Host: @GTersalvi
🎙️ Co-host: @jozinetm
🎙️ Faculty: Profs @markcpetrie20 & @DukeHFDoc
📺 Watch here: https://t.co/naxBobeSb6
#HeartFailure #AcuteHeartFailure @escardio #HFAjournalclub #HFAyoung
HFSA Annual Scientific Meeting early bird registration opens next month! Be the first to know when it opens so you don't miss out on savings and stay updated on all things #HFSA2026
Sign up: 🔗https://t.co/Q8gDmL9Bu4
Congrats to @PaulaRambarat for her presentation here @escardio HF meeting. Novel insights about GDMT in severe HF. Notable opportunities w SGLT2i. What will the future hold w omecamtiv? Await COMET results #hfcongress26
#JACCHF honors Dr. @JLHarrington_MD w/ the Christopher O'Connor Award for Outstanding Scholarship for her innovative research, "HFpEF Across the Spectrum of BMI: Hemodynamic & Echocardiographic Characteristics & Outcomes" 🎉 https://t.co/Pl13c0uI2U #ACC26#TheFaceOfCardiology
Need leading experts to design your next global #CV trial? Let's talk. The DCRI brings decades of expertise to every collaboration. Reach out to Claire Beard to schedule a meeting at #ACC26. [email protected] | Learn more: https://t.co/FMz0TkJ9VL #trialdesign#CardioX
And properly evaluate that promising subgroup in follow-up prospective RCT
#COMETHF n=1,800 OM vs PBO in chronic HF w severely reduced LVEF
https://t.co/PzPjZRIvxA
Powered for CVd, HF event, LVAD transplant,or stroke
Isn’t that how evidence-based medicine is supposed to work?
Want to improve heart failure management in your practice? Adam D. DeVore, MD, MHS summarizes the top takeaways from the latest scientific statement from HFSA and @AAHFN on integrated health technologies, out now in @JCardFail.
#HeartHealth#DigitalHealth#HealthTech@uicnursing
Applications are now open for HFSA Fellowship (FHFSA) — a professional designation recognizing outstanding commitment and leadership in heart failure care.
Earning FHFSA status highlights your contributions to clinical care, research, education, and service within the heart...
“What brought you to heart failure?”
In this special episode, six HFSA past presidents share the defining moments, mentors, and clinical experiences that shaped their careers — from hemodynamics and early HF trials to transformative ICU care. Their reflections offer a rare look at how leaders in our field found purpose and direction.
Listen here: 🔗 https://t.co/AgeqbTCsp1
#HFBeat @nancy_m_albert@BiykemB @JamesCFangMD @MarkDrazner@DukeHFDoc@MHBeasleyMD@priyaumapathi
Today is the 16th Anniversary of the passing of a @hopkinsheart & @BrighamWomens 🫀leader & legendary figure Dr. Ken Baughman. Many of us consider him to be pivotal in our career paths. We miss KLB greatly.